-
-
-
-
-
-
-
Braxia Scientific Reports Q1 2023 Financial Results; Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients
-
-
-
-
-
-
-
Braxia Scientific to Present at H.C. Wainwright Global Investment Conference, Miami from May 24-26, 2022
-
-
-
-
-
-
-
Braxia Scientific CEO Dr. Roger McIntyre to Join Advisory Board of At-Home Telemedicine Platform KetaMD
-
-
-
-
-
-
-
Braxia Scientific Reports First Quarter 2022 Financial Results; Company Achieves 80% Revenue Growth from Expanding Clinic Patient Base
-
-
-
-
-
-
-
/R E P E A T -- Braxia Scientific Announces Symbol Change on OTC markets to "BRAXF"/
-
-
-
1,220,823 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

